Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
abbreviated, accommodate, admit, admitted, ADR, aforementioned, arguing, carryforward, closure, collaboration, compelling, compounding, deconsolidated, deconsolidation, detriment, DIP, disagreement, dismissal, dismissed, diversion, divestiture, Document, documentation, doubtful, EBA, efficient, Exhibit, exploration, explore, exploring, greatly, ID, illiquid, illiquidity, Inline, insolvency, insolvent, Interactive, judgement, Linkbase, loan, lost, multifaceted, NaN, overstated, Prepaid, prioritization, reaction, revert, scenario, Schema, smaller, substance, summoned, supervisor, Taxonomy, transparent, understated, understating, uneven, unfairly, view, vigorously, waiting, XBRL
Removed:
abandonment, accelerate, acid, aid, appealed, assumption, assured, attract, avoidance, burden, cancelled, capitalize, circumstance, commenced, commercialization, common, concluding, conjunction, cooperate, correctly, Defense, delayed, directed, discovered, distinct, diversification, downgrade, exhaustive, expensed, formula, fumaric, GBP, half, hired, inaccurate, largely, managerial, MMF, motivate, Nunc, peer, piggyback, planning, political, Presently, preservation, publish, quoted, redefining, reliably, rental, residing, rest, scheme, selected, Sheet, shortly, situation, small, stage, standalone, stringent, subsidize, suggest, systematic, Tabular, therewith, undergoing, underwriting, unrestricted, valuation, variability, varying, world, yielded
Filing tables
Filing exhibits
FWPAY similar filings
Filing view
External links
Exhibit 15.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements on Form F-3 (No. 333-261626) and Form S-8 (Nos. 333-203313 and 333-261624) of our report dated April 8, 2022, with respect to the consolidated financial statements of Forward Pharma A/S included in this Annual Report (Form 20-F) for the year ended December 31, 2021.
| |
/s/ EY Godkendt Revisionspartnerselskab | |
Copenhagen, Denmark | |
April 8, 2022 | |